44 results on '"Ahlstrom, Jennifer M."'
Search Results
2. Supplement use habits and perceptions in patients with plasma cell disorders.
3. The effect of care team-patient relationship on decision-making in relapsed/refractory multiple myeloma.
4. The Experience and Needs of Myeloma Patients: Exploring Race and Ethnicity
5. Unraveling the Dynamics of Protein Secretion in Multiple Myeloma: A Comparative Study of Non-Secretory Patterns and Disease Evolution
6. Cannabis and Cannabinoid Use and Perceptions in Patients with Plasma Cell Disorders: A National Healthtree Foundation for Multiple Myeloma Survey
7. Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group.
8. Nutrition perceptions, needs and practices among patients with plasma cell disorders
9. HealthTree Cure Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles and Accelerate Research in Multiple Myeloma
10. P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP
11. Patient perspectives on BCMA-targeted therapies for multiple myeloma: A survey conducted in a patient advocacy group.
12. Integrative medicine in multiple myeloma and plasma cell disorders
13. Physical Activity and Patient-Reported Outcomes in Monoclonal Plasma Cell Disorders.
14. Exploratory Analysis of Efficacy and Toxicity in CAR T-Cell Therapy for Multiple Myeloma Using Real-World Data
15. The Side Effect Prevalence and Severity of Multiple Myeloma Doublet Vs Triplet Induction Therapy: A Retrospective Comparison of Patients Older Than 68 Years
16. Abstract A004: What are the top myeloma patient concerns at and since diagnosis of Mexicans, Hispanics and Latinos?
17. The Relationship between Therapeutic Pressure and Multiple Myeloma Risk Stratification: A 5 Year Real-World-Data Analysis
18. Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study
19. What Are the Top Myeloma Patient Concerns at and Since Diagnosis?
20. Microbial Changes in Response to a Plant-Based Diet and/or Supplements in SMM Patients: A National Multi-Arm Randomized Prospective Telehealth Study Via Healthtree: The Nutrition Prevention (NUTRIVENTION-2) Study
21. Clinician and Patient Perspectives on Treatment Decision-Making in Multiple Myeloma: A Qualitative Survey
22. A Retrospective Comparison of the Side Effect Prevalence and Severity of Multiple Myeloma Triplet Vs Quadruplet Induction Therapy
23. The Top Concerns at and Since Diagnosis: Standard v. High Risk Myeloma Patients
24. Physical Activity in Patients with Monoclonal Gammopathies - a Healthtree Cure Hub Study
25. A survey on the patient perspective on cure in multiple myeloma
26. Association between dexamethasone exposure and visually significant cataracts in multiple myeloma.
27. Abstract 6287: Comparison of multiple myeloma provider for Black Americans and Caucasian Americans
28. Abstract 6286: Relationship of ABO blood groups and length of survival of multiple myeloma patients
29. A patient perspective on cure in multiple myeloma: A survey of over 1,500 patients.
30. Early intervention for high-risk and low-risk of progression for patients with smoldering multiple myeloma.
31. Geographic disparity between patients with multiple myeloma (non-Whites and Whites).
32. Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data
33. Utilizing HealthTree ® Cure Hub's Real-World Data to Assess Treatment Management of Patients with Multiple Myeloma during the COVID-19 Pandemic
34. Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy
35. Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic
36. Understanding Patterns of Supplement Use among Plasma Cell Disorder Patients
37. 553 - Exploratory Analysis of Efficacy and Toxicity in CAR T-Cell Therapy for Multiple Myeloma Using Real-World Data
38. 552 - The Side Effect Prevalence and Severity of Multiple Myeloma Doublet Vs Triplet Induction Therapy: A Retrospective Comparison of Patients Older Than 68 Years
39. Unraveling the Dynamics of Protein Secretion in Multiple Myeloma: A Comparative Study of Non-Secretory Patterns and Disease Evolution
40. Age-Based Comparison of Dara-Rvd, Krd and Rvd Induction Therapies during the First Line of Therapy for Multiple Myeloma Patients
41. Multiple Myeloma Patient Perceptions of Minimal Residual Disease Testing
42. Age-Based Comparison of Stem Cell Transplantation during the First Line of Therapy for Multiple Myeloma Patients
43. Doctor-Patient Relationships and Patient Satisfaction in Multiple Myeloma: Implications of Shared Decision-Making and Racial Disparities.
44. Real-world analysis of D-RVd v. RVd at induction for newly diagnosed transplant eligible multiple myeloma patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.